Ivan P. Gergel, EVP, Research & Development at ENDO PHARMACEUTICALS HOLDINGS INC (ENDP), sold 30,603 shares at $35.77 ($1.1M) on 2011-03-02, disclosed to the SEC on 2011-03-03.
Scheduled sale ($1.1M) by EVP, Research & Development under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| NKTR | SELL | 2017-07-20 | $1.2M | — | Filing → |
| NKTR | SELL | 2017-07-13 | $1.9M | — | Filing → |
| NKTR | SELL | 2017-05-18 | $28K | — | Filing → |